Atom Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$11.2M |
| 2 |
Walt Disney
DIS
|
+$5.08M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.85M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$3.59M |
| 5 |
Ventas
VTR
|
+$3.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$7.66M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.66M |
| 3 |
Invitation Homes
INVH
|
+$2.69M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$2.6M |
| 5 |
Adtran
ADTN
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Financials | 12.36% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Real Estate | 9.52% |
| 5 | Healthcare | 7.57% |
Similar funds
Atom Investors's Q3 2022 Portfolio in Review
As of Q3 2022, Atom Investors held 400 positions worth $284M, up 24% from $229M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Atom Investors deployed $71.3M of net new capital in Q3 2022, opening 154 new positions and adding to 56 existing holdings. Its largest new stake was Ventas: 65,844 shares worth $2.65M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $7.66M trimmed.
- Atom Investors's largest Q3 2022 buy was Ventas: 65,844 shares worth $2.65M.
- Atom Investors added most to Microsoft in Q3 2022, an estimated $11.2M increase.
- Atom Investors's biggest Q3 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $7.66M.
- Atom Investors fully exited Encompass Health in Q3 2022, selling an estimated $2.37M.
- Atom Investors's ten largest holdings make up 26% of its $284M portfolio in Q3 2022.
- Atom Investors opened 154 new positions and closed 126 in Q3 2022.
- Atom Investors's portfolio value rose 24% quarter-over-quarter to $284M.
Based on Atom Investors's 13F filing for Q3 2022, filed 8 Nov 2022.